Reason for request

Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals: Box of 1 - CIP 379 253-3 and Inclusion on the list of medicines approved for use by hospitals: Box of 4 - CIP 377 450-6

-


Clinical Benefit

Substantial

The actual benefit of this medicinal product is substantial.


Clinical Added Value

no clinical added value

In the absence of comparative studies, the Transparency Committee considers that LUMINITY™ does not provide an improvement in actual benefit (IAB V) in terms of efficacy and safety with regards to the comparator medicines SONOVUE and OPTISON.


Contact Us

Évaluation des médicaments
All our publications